Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2009, Article ID 457418, 6 pages
http://dx.doi.org/10.1155/2009/457418
Clinical Study

Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study

1Department of Pulmonology, Erasmus MC-Daniel Den Hoed Cancer Center, Rotterdam, The Netherlands
2Department of Pulmonology, Amphia Hospital, Breda, The Netherlands
3Department of Pulmonology, St. Franciscus Gasthuis, Rotterdam, The Netherlands
4Department of Pulmonology, St. Antonius, Nieuwegein, The Netherlands
5Department of Trials and Statistics, Erasmus MC-Daniel Den Hoed Cancer Center, Rotterdam, The Netherlands

Received 17 April 2009; Revised 17 July 2009; Accepted 19 August 2009

Academic Editor: James L. Mulshine

Copyright © 2009 V. Surmont et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

V. Surmont, J. G. J. V. Aerts, K. Y. Tan, et al., “Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study,” Journal of Oncology, vol. 2009, Article ID 457418, 6 pages, 2009. https://doi.org/10.1155/2009/457418.